FDA Prevails in Legal Battle Over Ozempic and Wegovy Drug Listings

The U.S. Food and Drug Administration (FDA) recently navigated legal challenges regarding its handling of Ozempic and Wegovy, popular drugs known for their weight loss efficacy. Allegations suggested that the FDA unlawfully favored major pharmaceutical companies by eliminating more affordable generic versions of these medications. However, the case was dismissed by a Texas federal judge, sparing the FDA from the accusations put forth by two compounding pharmacies. For further details, please refer to the original report.